Cathepsin L (3.4.22.15)

Industry

CPC
C12Y304/22015

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y304/00Hydrolases acting on peptide bonds

Current Industry

C12Y304/22015Cathepsin L (3.4.22.15)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of treatment of collagen-mediated diseases and conditions
- Patent number 9,833,498
- Issue date Dec 5, 2017
- Halozyme, Inc.
- Gilbert Keller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment of cellulite
- Patent number 9,775,889
- Issue date Oct 3, 2017
- Halozyme, Inc.
- Gilbert Keller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety...
- Patent number 9,481,876
- Issue date Nov 1, 2016
- Research Foundation of the City University of New York
- Sanjai Kumar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human cathepsin L2 protein, gene encoding said protein and use thereof
- Patent number 6,800,473
- Issue date Oct 5, 2004
- Daiichi Fine Chemical Co., Ltd.
- Inigo Santamaría
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for reducing blood insulin levels by reducing in vivo cathep...
- Patent number 6,620,844
- Issue date Sep 16, 2003
- NewMillennium Pharmaceutical, Inc.
- Hamilton H. Yong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
CATHEPSIN L INHIBITORS AND PROBES COMPRISING VINYL SULFONATE MOIETY...
- Publication number 20150337286
- Publication date Nov 26, 2015
- Research Foundation of the City University of New York
- Sanjai Kumar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IN VIVO TEMPORAL CONTROL OF ACTIVATABLE MATRIX-DEGRADING ENZYMES
- Publication number 20140271609
- Publication date Sep 18, 2014
- Gilbert Keller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
In vivo temporal control of activatable matrix-degrading enzymes
- Publication number 20100003237
- Publication date Jan 7, 2010
- Gilbert Keller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and composition for treating obesity by targeting cathespin
- Publication number 20070123483
- Publication date May 31, 2007
- Guo-Ping Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and composition for reducing blood sugar levels or fat stora...
- Publication number 20060216297
- Publication date Sep 28, 2006
- Guo-Ping Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and composition for treating obesity by targeting cathepsin
- Publication number 20040009891
- Publication date Jan 15, 2004
- NewMillennium Pharmaceutical, Inc.
- Hamilton H. Yong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for reducing blood insulin levels by reducing in vivo cathep...
- Publication number 20030054984
- Publication date Mar 20, 2003
- Hamilton H. Yong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for treating diabetes by reducing in vivo cathepsin L activity
- Publication number 20030050260
- Publication date Mar 13, 2003
- Hamilton H. Yong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Cathepsin L (3.4.22.15)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Methods of treatment of collagen-mediated diseases and conditions

Methods of treatment of cellulite

Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety...

Human cathepsin L2 protein, gene encoding said protein and use thereof

Method for reducing blood insulin levels by reducing in vivo cathep...

Patents Applicationslast 30 patents

CATHEPSIN L INHIBITORS AND PROBES COMPRISING VINYL SULFONATE MOIETY...

IN VIVO TEMPORAL CONTROL OF ACTIVATABLE MATRIX-DEGRADING ENZYMES

In vivo temporal control of activatable matrix-degrading enzymes

Method and composition for treating obesity by targeting cathespin

Method and composition for reducing blood sugar levels or fat stora...

Method and composition for treating obesity by targeting cathepsin

Method for reducing blood insulin levels by reducing in vivo cathep...

Method for treating diabetes by reducing in vivo cathepsin L activity